Concepedia

Yves Girard

YG

Statistics

Publications

64

Citations

3.3K

H-Index

31

Active since

1973

Affiliations

Merck Canada Inc. (Canada)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

United States Military Academy

Yves Girard is an author at Merck Canada Inc. (Canada) specializing in pharmacology, medicinal chemistry, and medicine.

Publications per year

1973–2010

64

Publications

64

Etoricoxib (MK-0663): Preclinical Profile and Comparison with Other Agents That Selectively Inhibit Cyclooxygenase-2

Denis Riendeau, M. David Percival, Christine Brideau et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 460 citations · Full text

, , +13

Quinolines as potent 5-lipoxygenase inhibitors: Synthesis and biological profile of L-746,530

Daniel Dubé, Marc Blouin, Christine Brideau et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 272 citations · Full text

, , +11

Measuring leukotrienes of slow reacting substance of anaphylaxis: development of a specific radioimmunoassay.

Edward C. Hayes, D. Lombardo, Yves Girard et al. · The Journal of Immunology · 1983 · 202 citations

, , +10

Urinary leukotriene E4 levels during early and late asthmatic responses

Joshua Rokach, Diane Ethier, André Cartier et al. · Journal of Allergy and Clinical Immunology · 1990 · 196 citations

, , +6

2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: Selective and orally active cyclooxygenase-2 inhibitors

Richard W. Friesen, Christine Brideau, Chi Chung Chan et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 128 citations · Full text

, , +9

1–5 of 64